✦ LIBER ✦

Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck

✍ Scribed by Mohan Suntharalingam; Young Kwok; Olga Goloubeva; Arti Parekh; Rodney Taylor; Jeffrey Wolf; Ann Zimrin; Scott Strome; Robert Ord; Kevin J. Cullen

Book ID: 118455589
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 209 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.02.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III study of concurrent radiothe

A phase III study of concurrent radiotherapy with carboplatin or weekly paclitaxel in patients with advanced squamous cell head and neck cancer (SCHNC)

✍ C. Andreadis; J. Sidiropoulos; K. Vahtsevanos; J. Thomaidis; E. Destouni; D. Kas 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

The evaluation of amifostine for mucosal

The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT)

✍ Mohan Suntharalingam; Jerry Jaboin; Rodney Taylor; Jeffrey Wolf; Madan Banglore; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Cetuximab combined with radiotherapy: An

Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

✍ J. Bernier; D. Schneider 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Marshall Posner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Phase II randomized study of concomitant

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Lori Wirth; Rosemary Costello; Linda Weeks; Marshall Posner 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB